|
Apr 10
|
Harvard Bioscience Announces CFO Transition
|
|
Apr 9
|
Estimating The Fair Value Of Harvard Bioscience, Inc. (NASDAQ:HBIO)
|
|
Mar 13
|
Harvard Bioscience Full Year 2024 Earnings: EPS Beats Expectations
|
|
Mar 13
|
Q4 2024 Harvard Bioscience Inc Earnings Call
|
|
Mar 12
|
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
|
|
Mar 12
|
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results
|